Table 2 Socio-demographic and clinical characteristics of 141 patients administered warfarin at Korle-bu Teaching Hospital in Accra
From: Genetic polymorphisms of patients on stable warfarin maintenance therapy in a Ghanaian population
Characteristic | Frequency, % |
|---|---|
Age (years) (N = 141) | |
Median (inter-quartile range) | 48 (34–58) |
Gender (N = 141) | |
Female | 79 (56.0) |
Body mass index (N = 141) | |
Normal (18.00–24.99 kg/m2) | 55 (39.0) |
Overweight/Obese (≥ 25.00 kg/m2) | 86 (61.0) |
Warfarin duration (months) (N = 139) | |
Median (inter-quartile range) | 24 (10–72) |
Diagnosis (N = 140) | |
Mitral valve replacement | 63 (45.0) |
Deep vein thrombosis | 51 (36.4) |
Atrial fibrillation | 10 (7.2) |
Pulmonary embolism | 16 (11.4) |
Presence of side effects (N = 141) | |
Yes | 27 (19.1) |
No | 114 (80.9) |
Other medication given (N = 141) | |
Yes | 76 (53.9) |
No | 65 (46.1) |